ONWARD MEDICAL BV EO -12 (F:63E) — Market Cap & Net Worth
Market Cap & Net Worth: ONWARD MEDICAL BV EO -12 (63E)
ONWARD MEDICAL BV EO -12 (F:63E) has a market capitalization of $187.36 Million (€160.26 Million) as of August 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #16736 globally and #1591 in its home market, demonstrating a -3.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ONWARD MEDICAL BV EO -12's stock price €2.31 by its total outstanding shares 69528511 (69.53 Million). Review ONWARD MEDICAL BV EO -12 debt and liabilities to assess the company's total debt and financial obligations.
ONWARD MEDICAL BV EO -12 Market Cap History: 2021 to 2026
ONWARD MEDICAL BV EO -12's market capitalization history from 2021 to 2026. Data shows change from $812.05 Million to $187.36 Million (-29.38% CAGR).
ONWARD MEDICAL BV EO -12 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ONWARD MEDICAL BV EO -12's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
93.33x
ONWARD MEDICAL BV EO -12's market cap is 93.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $503.16 Million | $104.00K | -$32.77 Million | 4838.09x | N/A |
| 2023 | $239.79 Million | $68.00K | -$36.18 Million | 3526.38x | N/A |
| 2024 | $471.46 Million | $229.00K | -$35.73 Million | 2058.78x | N/A |
| 2025 | $352.78 Million | $3.78 Million | -$41.79 Million | 93.33x | N/A |
Competitor Companies of 63E by Market Capitalization
Companies near ONWARD MEDICAL BV EO -12 in the global market cap rankings as of August 4, 2026.
Key companies related to ONWARD MEDICAL BV EO -12 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #423 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #564 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $470.72 |
| #423 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $759.24 |
| #541 | Argen-X | BR:ARGX | $49.55 Billion | €722.20 |
| #564 | UCB SA | BR:UCB | $47.34 Billion | €221.40 |
ONWARD MEDICAL BV EO -12 Historical Marketcap From 2021 to 2026
Between 2021 and today, ONWARD MEDICAL BV EO -12's market cap moved from $812.05 Million to $ 187.36 Million, with a yearly change of -29.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €187.36 Million | -46.89% |
| 2025 | €352.78 Million | -25.17% |
| 2024 | €471.46 Million | +96.61% |
| 2023 | €239.79 Million | -52.34% |
| 2022 | €503.16 Million | -38.04% |
| 2021 | €812.05 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of ONWARD MEDICAL BV EO -12 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $187.36 Million USD |
| MoneyControl | $187.36 Million USD |
| MarketWatch | $187.36 Million USD |
| marketcap.company | $187.36 Million USD |
| Reuters | $187.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ONWARD MEDICAL BV EO -12
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more